Exelixis, Inc. (EXEL)
43.96
-1.48
(-3.26%)
USD |
NASDAQ |
Jan 16, 16:00
43.98
+0.02
(+0.05%)
After-Hours: 20:00
Exelixis Market Cap: 11.79B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vanda Pharmaceuticals, Inc. | 441.45M |
| ADMA Biologics, Inc. | 4.120B |
| Aldeyra Therapeutics, Inc. | 278.55M |
| Natera, Inc. | 32.25B |
| Merck & Co., Inc. | 270.12B |
Market Cap Related Metrics
| PE Ratio | 18.51 |
| PS Ratio | 5.498 |
| PEG Ratio | 0.3603 |
| Price to Book Value | 5.455 |
| Price to Free Cash Flow | 16.13 |
| Price | 43.96 |
| Earnings Yield | 5.40% |
| PEGY Ratio | 0.3603 |
| Operating PE Ratio | 15.34 |
| Normalized PE Ratio | 18.12 |